Metagenome analyses identify human endogenous retrovirus–K113 (HML-2) subtype in glioblastoma. Reply.
Vaidya Govindarajan, … , Avindra Nath, Ashish H. Shah
Vaidya Govindarajan, … , Avindra Nath, Ashish H. Shah
Published December 15, 2023
Citation Information: J Clin Invest. 2023;133(24):e176406. https://doi.org/10.1172/JCI176406.
View: Text | PDF
Letter to the Editor Stem cells Virology

Metagenome analyses identify human endogenous retrovirus–K113 (HML-2) subtype in glioblastoma. Reply.

Abstract

Authors

Vaidya Govindarajan, Jay Chandar, Avindra Nath, Ashish H. Shah

×

Figure 1

Multiomic classification of GBM based on bulk RNA-Seq, single-cell RNA-Seq, proteomics, and immunophenotyping may confirm novel retroviral-enriched subtype.

Options: View larger image (or click on image) Download as PowerPoint
Multiomic classification of GBM based on bulk RNA-Seq, single-cell RNA-S...
AC, astrocytes; GPM, glycolytic/plurimetabolic; MES, mesenchymal; MTC, mitochondrial; NEU, neuronal; NPC, neural progenitor cells; OPC, oligodendrocytic precursor cells; PPR, proliferative/progenitor; scRNA-Seq, single-cell RNA-Seq. This figure was created with BioRender.